Characteristics of uterine bleeding associated with an oral contraceptive containing drospirenone in combination with estetrol: A multicenter observational study
Background. An unfavorable bleeding pattern is a common reason for refusing to continue hormonal contraception. Aim. To evaluate the characteristics of uterine bleeding when using a new combined oral contraceptive (COC) containing estetrol and drospirenone (Esteretta®). Materials and methods. A mult...
Saved in:
Main Authors: | Irina V. Kuznetsova (Author), Liudmila V. Evsyukova (Author) |
---|---|
Format: | Book |
Published: |
IP Berlin A.V.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The estetrol-drospirenone-containing contraceptive as a drug of choice for patients with mastalgia
by: Mekan R. Orazov, et al.
Published: (2023) -
The benefits of estetrol addition to drospirenone for contraception
by: Jean Michel Foidart, PhD, MD, et al.
Published: (2023) -
Sexual health of women using combined oral contraceptive containing estetrol and drospirenone: A prospective observational study
by: Mekan R. Orazov, et al.
Published: (2024) -
Effect of an estetrol/drospirenone contraceptive on sexual function in women of reproductive age
by: Mekan R. Orazov, et al.
Published: (2023) -
Efficacy and safety of drospirenone-containing microdosage combined oral contraceptive use with starting contraception
by: A R Khachaturian, et al.
Published: (2018)